China Menopause Supplements Market Size & Outlook, 2025-2033
China Menopause Supplements Market Insights
- As per Deep Market Insights insights, the China Menopause Supplements Market stood at USD 225.12 Million in 2024 and is anticipated to grow to USD 416.03 Million by 2033.
- The China market is expected to advance at a CAGR of 7.05% from 2026 through 2033.
- In 2024, Hormonal Supplements accounted for the highest share of the Product market size.
- During the forecast period, Hormonal Supplements is set to register the highest growth, making it the most lucrative Product segment.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2024, China accounted for 6.62% of the global Menopause Supplements Market size.
- By 2033, United States is expected to lead the global Menopause Supplements Market in terms of market size.
- Within Asia Pacific, China is projected to dominate the regional Menopause Supplements Market size by 2033.
- South East Asia is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 109.32 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 225.12 Million |
| Market Size In 2033 | USD 416.03 Million |
| Largest segment | Hormonal Supplements |
| Units | Revenue in USD Million |
| CAGR | 7.05% (2025-2033) |
| Segmnetation Covered | |
| Product |
|
| Form |
|
| Distribution Channel |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
China Menopause Supplements Market Product 2025-2033 (USD Million)
| Product | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hormonal Supplements | XX.x | XX.x | XX.x | 129.26 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Non-Hormonal Supplements | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
China Menopause Supplements Market Form 2025-2033 (USD Million)
| Form | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tablets | XX.x | XX.x | XX.x | 95.74 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Capsules | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Powders | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Liquids | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
China Menopause Supplements Market Distribution Channel 2025-2033 (USD Million)
| Distribution Channel | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Online | XX.x | XX.x | XX.x | 102.7 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pharmacies | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Health Stores | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.